Company Filing History:
Years Active: 2009-2024
Title: Tetsuji Matsudaira: Innovator in Pharmaceutical Chemistry
Introduction
Tetsuji Matsudaira is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target cancer treatment. With a total of 5 patents to his name, Matsudaira's work is recognized for its innovative approach to drug development.
Latest Patents
One of Matsudaira's latest patents involves a sulfonamide or sulfinamide compound that induces BRD4 protein degradation. This compound is noted for its potential as a therapeutic agent for cancer. The patent details a compound or a pharmaceutically acceptable salt that demonstrates superior action in inducing the degradation of BRD4 protein, which is crucial in cancer therapy.
Career Highlights
Matsudaira is currently associated with Mitsubishi Tanabe Pharma Corporation, where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new therapeutic strategies that could significantly impact cancer treatment.
Collaborations
Matsudaira collaborates with talented coworkers, including Maiko Hamada and Kazutoshi Sugawara. Their combined expertise contributes to the innovative research environment at Mitsubishi Tanabe Pharma Corporation.
Conclusion
Tetsuji Matsudaira's contributions to pharmaceutical chemistry highlight his role as a key innovator in cancer treatment. His ongoing research and patent developments continue to pave the way for new therapeutic options.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.